BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26214635)

  • 21. [Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil].
    Gao Y; Li Y; Yuan Z; Zhao L; Liu X; Gu D; Qian T; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):483-5. PubMed ID: 12485504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics.
    Radić-Kristo D; Planinc-Peraica A; Ostojić S; Vrhovac R; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):413-7. PubMed ID: 20698111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary gastrointestinal lymphomas: response to eradicative therapy and prognostic factors in 52 patients].
    Hernández JA; Ribera JM; Oriol A; Batlle M; Vaquero M; Flores A; Fernández-Llamazares J; Piñol M; Millá F; Feliu E
    Med Clin (Barc); 1998 Jan; 110(2):45-50. PubMed ID: 9580161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A proposed staging system for primary gastric lymphoma.
    Shimodaira M; Tsukamoto Y; Niwa Y; Goto H; Hase S; Hayakawa T; Nagasaka T
    Cancer; 1994 Jun; 73(11):2709-15. PubMed ID: 8194010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
    Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
    Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes for rectal carcinoid tumors according to a new (AJCC 7th edition) TNM staging system: a single institutional analysis of 122 patients.
    Kim MS; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    J Surg Oncol; 2013 Jun; 107(8):835-41. PubMed ID: 23505038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TNM Staging System for Nasal NK/T-Cell Lymphoma.
    Yan Z; Huang HQ; Wang XX; Gao Y; Zhang YJ; Bai B; Zhao W; Jiang WQ; Li ZM; Xia ZJ; Lin SX; Xie CM
    PLoS One; 2015; 10(6):e0130984. PubMed ID: 26098892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.
    Logsdon MD; Ha CS; Kavadi VS; Cabanillas F; Hess MA; Cox JD
    Cancer; 1997 Aug; 80(3):477-88. PubMed ID: 9241082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of prognostic scoring system to tumor node metastases 1992 and 1997 staging systems in gastric cancer patients.
    Atalay C; Kanliöz M; Altinok M
    Neoplasma; 2002; 49(5):323-8. PubMed ID: 12458331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma--Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System.
    Ohga S; Nakamura K; Shioyama Y; Sasaki T; Yamaguchi T; Yoshitake T; Terashima K; Asai K; Matsumoto K; Honda H
    Anticancer Res; 2015 Jun; 35(6):3591-7. PubMed ID: 26026132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
    Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
    Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K; Allen L; Yahalom J
    Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
    Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic value of metastatic lymph node ratio in adenocarcinoma of the gastroesophageal junction].
    Zhang HD; Ma Z; Tang P; Duan XF; Ren P; Yue J; Yu ZT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):822-6. PubMed ID: 24061985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.